Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00360581 · ClinicalTrials.gov registry record · Phase 1

Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study

A Phase 1 study of Smoking Cessation, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT00360581 is a Phase 1 study of Smoking Cessation that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00360581, a Phase 1 study of Smoking Cessation, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop strategies to maintain smoking abstinence initiated in pregnancy and prevent relapse in the postpartum period.

Conditions Studied

Interventions

  • BEHAVIORAL Yoga
  • BEHAVIORAL Yoga and Cognitive Behavioral Therapy

Study Locations (1)

Pennsylvania

  • University of Pittsburgh School of Nursing - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2006-04
Est. Completion 2008-01
Phase Phase 1

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00360581

The ClinicalTrials.gov registry entry for NCT00360581 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (94% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Yoga is the first listed.

NCT00360581 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00360581 about?

NCT00360581 is a clinical study titled "Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study". The purpose of this study is to develop strategies to maintain smoking abstinence initiated in pregnancy and prevent relapse in the postpartum period.

What is the current status of trial NCT00360581?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2006-04. Estimated completion is 2008-01.

What conditions does trial NCT00360581 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT00360581?

The interventions under investigation include: Yoga (BEHAVIORAL), Yoga and Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00360581?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00360581 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.